Arthur Winston
Affiliations: | Tufts University, Boston |
Area:
Management Business Administration, Industrial PsychologyGoogle:
"Arthur Winston"Mean distance: 53433
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Churchill D, Waters L, Ahmed N, et al. (2016) British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015. Hiv Medicine. 17: s2-s104 |
Underwood J, Winston A. (2016) Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive Individuals. Current Hiv/Aids Reports |
Winston A, Stöhr W, Antinori A, et al. (2015) Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy. Hiv Medicine |
Ashby J, Foster C, Garvey L, et al. (2015) Cerebral function in perinatally HIV-infected young adults and their HIV-uninfected sibling controls. Hiv Clinical Trials. 16: 81-7 |
Vera JH, Jackson A, Dickinson L, et al. (2015) The pharmacokinetic profile of raltegravir-containing antiretroviral therapy in HIV-infected individuals over 60 years of age. Hiv Clinical Trials. 16: 39-42 |
Arenas-Pinto A, Winston A, Stöhr W, et al. (2014) Neurocognitive function in HIV-infected patients: comparison of two methods to define impairment. Plos One. 9: e103498 |
Williams I, Churchill D, et al. (2014) British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.). Hiv Medicine. 15: 1-85 |
Garvey LJ, Pavese N, Politis M, et al. (2014) Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART. Aids (London, England). 28: 67-72 |
Winston A, Arenas-Pinto A, Stöhr W, et al. (2013) Neurocognitive function in HIV infected patients on antiretroviral therapy. Plos One. 8: e61949 |
Mora-Peris B, Croucher A, Else LJ, et al. (2013) Pharmacokinetic profile and safety of 150 mg of maraviroc dosed with 800/100 mg of darunavir/ritonavir all once daily, with and without nucleoside analogues, in HIV-infected subjects. The Journal of Antimicrobial Chemotherapy. 68: 1348-53 |